BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Aratana Therapeutics to Highlight Pet Therapeutic Market Need and Support of Pet Adoption During the NASDAQ Stock Market Closing Bell on October 18, 2013


10/15/2013 10:07:51 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

KANSAS CITY, Kan. and BOSTON, Oct. 15, 2013 /PRNewswire/ -- Aratana Therapeutics (Nasdaq: PETX), a development-stage biopharmaceutical company focused on the licensing, development and commercialization of innovative medications for pets (pet therapeutics), today announced that it will ring The NASDAQ Stock Market Closing Bell on October 18, 2013 and has invited the Mayor's Alliance for NYC's Animals, a leading New York City rescue organization, and several of its adoptable pets, to share in the event. The ceremony will commemorate Aratana's successful initial public offering on June 27, 2013 and serve as a forum to advocate for the health and well being of pets through better medications and more humane treatment.

Steven St. Peter, M.D., President and Chief Executive Officer of Aratana Therapeutics, stated, "We are honored to ring The NASDAQ Stock Market Closing Bell on October 18, and even more honored to invite the Mayor's Alliance for NYC's Animals to participate in this special event. For Aratana, this is not only an occasion to celebrate our growth as a company and the burgeoning pet therapeutics market, but it's an opportunity to salute the Mayor's Alliance and the community of animal rescue organizations it represents for their tireless efforts to save the lives of countless pets, a mission that Aratana supports wholeheartedly."

Celebrating its 10th anniversary, the Mayor's Alliance is a non-profit coalition of more than 150 New York City-area animal rescue groups and shelters. In addition to serving as a powerful voice for its participating organizations, the Alliance offers essential programs and services that help save the lives of New York City's homeless animals. Since its 2003 founding, nearly a quarter-million dogs and cats have been saved as a result of this community collaboration, and New York City's animal euthanasia rate has dropped 74 percent, giving the city the lowest rate per capita of any major U.S. metropolis.

Jane Hoffman, president of the Mayor's Alliance for NYC's Animals, said, "We are grateful to Aratana for inviting us to participate in this exciting event. We look forward to adding to the celebration by giving several of our adoptable pets the chance to show themselves off on a national stage. "

About Aratana Therapeutics
Aratana Therapeutics is a development-stage biopharmaceutical company focused on the licensing, development and commercialization of innovative medications for pets, or pet therapeutics. Aratana believes that it can leverage the investment in the human biopharmaceutical industry to bring therapeutics to pets in a capital and time efficient manner. Aratana's strategy is to in-license proprietary compounds from human biopharmaceutical companies and to develop these product candidates into therapeutics specifically for use in pets. Aratana believes the development and commercialization of these therapeutics will permit veterinarians and pet owners to manage pets' medical needs safely and effectively, resulting in longer and improved quality of life for pets. For more information, please visit www.aratana.com.

About Mayor's Alliance for NYC's Animals
The Mayor's Alliance for NYC's Animals is a 501(c)(3) non-profit charity that works with more than 150 partner rescue groups and no-kill shelters to offer important programs and services to save the lives of NYC's homeless animals. Receiving no government funding, we are supported by donations from foundations, corporations, and individuals. As we mark our tenth anniversary in 2013, we are committed to transforming New York City into a no-kill community by 2015: where no dogs or cats of reasonable health and temperament will be killed merely because they do not have homes. www.AnimalAllianceNYC.org

Contacts:
Tiberend Strategic Advisors, Inc.

Joshua Drumm, Ph.D. (investors)
jdrumm@tiberend.com; (212) 375-2664

Andrew Mielach (media)
amielach@tiberend.com; (212) 375-2694

Mayor's Alliance for NYC's Animals

Steve Gruber (media)
Steve@animalalliancenyc.org; 917-359-6003

SOURCE Aratana Therapeutics, Inc.



Help employers find you! Check out all the jobs and post your resume.


Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES